Haemonetics (HAE) Receivables - Other (2012 - 2022)

Haemonetics' Receivables - Other history runs 7 years deep, the most recent figure standing at $6.6 million for Q4 2022.

• In Q4 2022, Receivables - Other rose 20.0% year-over-year to $6.6 million; the TTM figure through Dec 2022 stood at $6.6 million (up 20.0% YoY), while the FY2022 annual figure was $5.5 million, up 14.58% from the prior year.
• Receivables - Other was $6.6 million for Q4 2022 at Haemonetics, down from $7.6 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $10.5 million in Q4 2018 to a low of $4.0 million in Q2 2018.
• Historically, Receivables - Other has averaged $6.1 million across 5 years, with a median of $5.6 million in 2019.
• The sharpest annual moves came in 2018 and 2021: Receivables - Other surged 147.62% in 2018, then tumbled 34.33% in 2021.
• A 5-year view of Receivables - Other shows it stood at $10.5 million in 2018, then declined by 23.81% to $8.0 million in 2019, then sank by 32.5% to $5.4 million in 2020, then dropped by 18.52% to $4.4 million in 2021, then surged by 50.0% to $6.6 million in 2022.
• The last three Receivables - Other figures came in at $6.6 million (Q4 2022), $7.6 million (Q4 2022), and $6.4 million (Q3 2022), per Business Quant data.